Answer
Raxone (idebenone) should be prescribed cautiously in patients with hepatic or renal impairment, as adverse events in patients with hepatic impairment have resulted in temporary interruption or discontinuation of treatment.
Sources for this answer
- Raxone 150 mg film-coated tabletsChiesi Limited · emc · SmPC §4.4 Special warnings and precautions for use · Version 7Document updated
Sources checked